Repaglinide and Mediastinal disorder - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Repaglinide?
Repaglinide has active ingredients of repaglinide. It is used in diabetes. Currently, eHealthMe is studying from 7,624 Repaglinide users.
What is Mediastinal Disorder?
Mediastinal disorder (disease of mediastinum) is found to be associated with 496 drugs and 155 conditions by eHealthMe. Currently, we are studying 478 people who have Mediastinal disorder.
Do you take Repaglinide and have Mediastinal disorder?Check whether Mediastinal disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Mediastinal disorder and when was it recovered:
Expand to all the drugs that have ingredients of repaglinide:
Alternative drugs to, pros and cons of Repaglinide:
- Repaglinide (7,624 reports)
Browse all side effects of Repaglinide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Mediastinal disorder treatments and more:
- Mediastinal disorder (478 reports)
All the drugs that are associated with Mediastinal disorder:
All the conditions that are associated with Mediastinal disorder:
How the study uses the data?
The study uses data from the FDA. It is based on repaglinide (the active ingredients of Repaglinide) and Repaglinide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Rasilez for High Blood Pressure? - 2 seconds ago
- Tessalon and Blood Urea Increased - 8 seconds ago
- Mercaptopurine and Deep Venous Thrombosis - 13 seconds ago
- Lyrica and Rayaldee drug interaction - 25 seconds ago
- Cefdinir and Lip Swelling - 34 seconds ago
- Vitamin K and Tamsulosin drug interaction - 34 seconds ago
- Cephalexin and Cross Sensitivity Reaction - 36 seconds ago
- Polysporin and Phytonadione drug interaction - 42 seconds ago
- Amphotericin B and Wound Dehiscence - 54 seconds ago
- Losartan Potassium And Hydrochlorothiazide and Lovastatin drug interaction - a minute ago